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Abstract
Background: Blood transfusion is one of the most common transmission pathways of hepatitis C virus (HCV). This
paper aims to provide a comprehensive and reliable tabulation of available data on the epidemiological
characteristics and risk factors for HCV infection among blood donors in Chinese mainland, so as to help make
prevention strategies and guide further research.
Methods: A systematic review was constructed based on the computerized literature database. Infection rates and
95% confidence intervals (95% CI) were calculated using the approximate normal distribution model. Odds ratios
and 95% CI were calculated by fixed or random effects models. Data manipulation and statistical analyses were
performed using STATA 10.0 and ArcGIS 9.3 was used for map construction.
Results: Two hundred and sixty-five studies met our inclusion criteria. The pooled prevalence of HCV infection
among blood donors in Chinese mainland was 8.68% (95% CI: 8.01%-9.39%), and the epidemic was severer in
North and Central China, especially in Henan and Hebei. While a significant lower rate was found in Yunnan.
Notably, before 1998 the pooled prevalence of HCV infection was 12.87% (95%CI: 11.25%-14.56%) among blood
donors, but decreased to 1.71% (95%CI: 1.43%-1.99%) after 1998. No significant difference was found in HCV
infection rates between male and female blood donors, or among different blood type donors. The prevalence of
HCV infection was found to increase with age. During 1994-1995, the prevalence rate reached the highest with a
percentage of 15.78% (95%CI: 12.21%-19.75%), and showed a decreasing trend in the following years. A significant
difference was found among groups with different blood donation types, Plasma donors had a relatively higher
prevalence than whole blood donors of HCV infection (33.95% vs 7.9%).
Conclusions: The prevalence of HCV infection has rapidly decreased since 1998 and kept a low level in recent
years, but some provinces showed relatively higher prevalence than the general population. It is urgent to make
efficient measures to prevent HCV secondary transmission and control chronic progress, and the key to reduce the
HCV incidence among blood donors is to encourage true voluntary blood donors, strictly implement blood
donation law, and avoid cross-infection.
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Chronic infection with hepatitis C virus (HCV) is a
major and growing public health problem, which could
easily lead to chronic liver disease, cirrhosis and even
hepatocellular carcinoma [1]. The prevention and con-
trol of HCV infection showed complexity and challenge
in describing geographic distribution of HCV infection,
determining its associated risk factors, and evaluating
cofactors that accelerate hepatitis C progression. Esti-
mated 170 million persons are infected with HCV
worldwide and more than 3.5 million new sufferers
occurred annually [2]. According to the national epide-
miological survey of viral hepatitis from 1992 to 1995,
average anti-HCV positive rate was 3.2% in the general
Chinese population, amounting to more than 30 million
infected individuals [3].
The rapid global spread of HCV is believed to have
occurred primarily because of efficient transmission
through blood transfusion and parenteral exposures with
contaminated equipment [4]. Blood donors, particularly
t h o s et h a tr e l yo nb l o o dd o n a t i o na sas o u r c eo fi n c o m e ,
had a very high prevalence of HCV infection [5]. Recent
studies have reported that the current residual risk of
transfusion-transmitted HCV infection in China is about
1 in 40,000-60,000 donations, higher than that found in
more developed countries [6]. With the implemention of
blood donation law in 1998, many blood centers relied
on other methods to motivate donors, mostly through
employer-organized blood collection, but these donors
may not have been true volunteers, as they may be
coerced by the employer to some extent. In recent years,
t h et r u ev o l u n t a r yd o n o r sa r e gradually becoming the
main source of blood donation in many blood centers in
China [7]. Among paid blood donors, the HCV preva-
lence has reached 5.7% or higher [8]. However, among
employer-organized donors and volunteer donors, the
HCV prevalence was reported at lower level between 1.1-
2.3%, and 0.46%, respectively [7,9].
A large amount of studies have been done in the last
decade on HCV infection and its associated risk factors
among blood donors. However, many of them drew
incompatible or even contradictory conclusion and the
utilization of these statistics are therefore limited. This
paper reviews on the available studies so as to provide
comprehensive and reliable epidemiological characteris-
tics of HCV infection among blood donors in China,
which is speculated to help make prevention strategies
and guide further research.
Methods
Literature search
Literatures on the HCV prevalence among blood donors
in China were acquired through searching PubMed,
Embase, China National Knowledge Infrastructure
(CNKI), and Wanfang Database from 1990 to 2010. In
order to search and include related studies as many as
possible, we used combinations of various key words,
including hepatitis C virus or HCV, blood donors, and
China or Chinese Mainland.
Selection and data abstraction
All the potentially relevant papers were reviewed inde-
pendently by two investigators through assessing the
eligibility of each article and abstracting data with stan-
dardized data-abstraction forms. Disagreements were
resolved through discussion. The following information,
though some studies did not contain all of them, were
extracted from the literatures: first author’s name, publi-
cation date, study period, province of sample, blood
donor recruitment methods (paid blood donors,
employer-organized donors, or true volunteer donors),
type of blood donation (categorized as plasma donors
and whole blood donors), sampling size, the number of
subjects infected with HCV, HBV, and HIV or co-
infected with two or three of these viruses, gender, age
(18-30 years and 31-60 years), and blood type, etc.
The inclusion criteria were: (1) studies in the men-
tioned four databases with full text, despite the language
of original text; (2) studies reporting anti-HCV positive
rates among blood donors in Chinese Mainland; (3) stu-
dies using anti-HCV as a detection index of HCV. The
exclusion criteria were: (1) studies without specific sam-
ple origins; (2) studies with overlapping time intervals of
sample collection from the same origin; (3) studies with
a sample size less than 50; (4) studies that failed to pre-
sent data clearly enough or with obviously paradoxical
data.
Statistical analysis
In our review, random effect models were used for
meta-analysis, considering the possibility of significant
heterogeneity between studies which was tested with the
Qt e s t( P < 0.10 was considered indicative of statistically
significant heterogeneity) and the I
2statistic (values of
25%, 50% and 75% are considered to represent low,
medium and high heterogeneity respectively). Freeman-
Tukey arcsin transform to stabilize variances, and after
the meta-analysis, investigators can transform the sum-
mary estimate and the CI boundaries back to propor-
tions using sin function, the specific conversion details
can be seen in reference [10]. Stratified analyses were
performed by study locations, gender, age, study period,
blood donor recruitment methods, type of blood dona-
tion, and blood type. The Z or c
2 test was used to assess
the differences among the subgroups. Data manipulation
and statistical analyses were undertaken using the Statis-
tical Software Package (STATA) 10.0 (STATA Corpora-
t i o n ,C o l l e g eS t a t i o n ,T X ,U S A ,2 0 0 9 ) ,a n dA r c G I S9 . 3
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construction.
Results
According to the literature search strategies, 726 studies
(90 studies in PubMed, 636 studies in CNKI and Wan-
fang database) were identified, but 461 studies were
excluded based on the inclusion and exclusion criteria
(Figure 1). There were 11 studies in English [8,9,11-19]
and 254 studies in Chinese [20-273] of the finally
adopted 265 studies.
General information of samples
A total of 4519313 blood donors between the ages of 18
to 60 were included, with a wide range of blood dona-
tion frequency from 1 to more than 50 times. Some
donors had a duration (the period from the first blood
donation to when selected in original research) longer
than 15 years. The majority of blood donors were men,
approximately 57.72% (101319/175540), while women
accounted for 42.28% (74221/175540). The occupation
of blood donors was widely distributed. Voluntary blood
donors mainly came from college students, health care
providers, officials, and military from Chinese People’s
Liberation Army (PLA), while paid blood donors were
mostly from peasants, low-wage workers, and unem-
ployed individuals.
The blood samples mainly came from blood banks,
hospitals, and Centers for Disease Control and Preven-
tion (CDC). The studies of our review involved in the
following regions of 29 provinces and cities: Central
China (Hunan, Hubei, Henan), North China (Beijing,
Title Screen
Abstract Review
Full Text Review
Relevant studies (n=617)
Duplicates (n=109)
Not relevant (n=157)
Not blood donors (n=21)
Not HCV (n=15)
Not Chinese mainland (n=13)
Sample size less than 50 (n=62)
Reviews (n=36)
Letters (n=4 )
Editorials (n=2)
Conference abstracts (n=5)
No original data (n=21)
The same sample origin (n=16)
265 studies finally included
PubMed (n=90)
CNKI (n=567)
Wangfang Database(n= 69)
Total (n=726)
Potentially appropriate studies 
for inclusion (n=302)
Figure 1 Results of the systematic literature search.
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Page 3 of 14Hebei, Shanxi, Tianjin, Inner Mongolia), South China
(Guangdong, Guangxi), Northwest China(Shanxi, Gansu,
Ningxia, Qinghai, Xinjiang), Northeast China (Liaoning,
Jilin, Heilongjiang), Southwest China (Yunnan, Guizhou,
Sichuan, Chongqing), East China (Shandong, Jiangsu,
Anhui, Zhejiang, Fujian, Shanghai, Jiangxi).
Prevalence of HCV infection among blood donors in
Chinese mainland
Region
As seen in Table 1 and Figure 2, 3, the pooled prevalence
of HCV infection among blood donors in Chinese
mainland from 1990 to 2010 was 8.68% (95% CI: 8.01%-
9.39%). Dramatic geographic difference in pooled HCV
infection rates among blood donors was observed. The
epidemic was severest in North and Central China, where
the HCV infection rate were 13.45% (95%CI: 11.41%-
15.67%) and 14.74% (95%CI: 11.06%-18.80%), respectively.
The lowest prevalence was in South China with the rate of
2.88% (95% CI: 2.19%-3.64%). Before 1998, the pooled pre-
valence of HCV infection was 12.87% (95% CI: 11.25%-
14.56%) among blood donors, with the highest rates found
in Henan (35.04%, 95% CI: 23.62%-47.41%), then Hebei
(29.26%, 95% CI: 19.63%-39.98%), and then the pooled
Table 1 Prevalence of HCV infection among blood donors at different regions
Study
location
Province
of study
Total
b Before 1998 After 1998
No Prevalence %
(95%CI)
No Prevalence %
(95%CI)
No Prevalence %
(95%CI)
East
China
Anhui 21 11.25(6.56,17.04) 19 12.91(8.31,18.34) 2 0.90(0.01,3.14)
Fujian 4 3.38(2.19, 4.83) 4 3.38(2.19, 4.83)
Jiangsu 21 11.41(6.12, 18.07) 13 14.84(8.73,22.23) 7 3.83(0.75,9.13)
Jiangxi 6 5.65(1.52, 12.21) 4 5.15(2.31, 9.07) 1 0.38(0.26,0.52)
Shandong 27 6.34(5.00, 7.80) 17 8.37(5.84, 11.31) 7 1.64(1.26,2.07)
Shanghai 4 2.59(0.38, 6.66) 4 2.59(0.38, 6.66)
Zhejiang 12 2.02(1.06, 3.28) 8 3.08(1.40, 5.42) 4 0.79(0.30,1.51)
North
China
Beijing 9 2.95(1.78, 4.41) 7 3.53(1.84, 5.74)
Hebei 19 26.92(15.20,40.57) 18 29.26(19.63,39.98) 1 0.41(0.39,0.43)
Shanxi 9 14.63(8.73, 21.74) 5 24.17(18.14,30.77) 2 0.41(0.06,2.31)
Tianjin 5 2.35(0.98, 4.33) 2 1.97(0.32, 5.02) 2
IM
a 4 9.36(3.00, 18.76) 4 9.36(3.00, 18.76)
South
China
Guangdong 13 1.05(0.65, 1.54) 5 1.41(0.87, 2.07) 8 0.91(0.49,1.47)
Guangxi 8 9.75(6.94, 12.98) 5 17.49(1.71, 44.67) 2 3.31(0.08,10.90)
Central
China
Hubei 11 10.81(5.51, 17.61) 8 13.04(6.41, 21.61) 3 5.54(0.63,14.84)
Hunan 13 8.01(3.22, 14.70) 8 17.11(9.81, 25.95) 3 0.55(0.35, 0.81)
Henan 26 20.63(12.98,29.53) 16 35.04(23.62,47.41) 9 3.83(1.75, 6.66)
Northwest Shanxi 6 11.25(4.81, 19.91) 4 17.42(3.60, 38.61) 1 1.99(1.95, 2.03)
Ningxia 2 0.69(0.10, 1.78) 1 1.18(1.03, 1.35) 1 0.32(0.29, 0.37)
Qinghai 3 2.60(0.10, 8.34) 2 3.59(0.00, 13.69) 1 1.10(0.511.91)
Gansu 6 2.60(5.44, 17.49) 3 23.32(3.62, 53.16) 2 0.83(0.29, 1.64)
Xinjiang 5 14.52(3.01, 32.54) 4 19.67(3.79, 43.83) 1 1.45(1.31, 1.58)
Southwest Sichuan 10 11.31(3.19, 23.49) 8 15.60(7.61, 25.77) 2 0.71(0.28, 1.34)
Yunnan 1 0.23(0.17, 0.29) 1 0.23(0.17, 0.29)
Guizhou 9 5.00(1.76, 9.78) 6 6.91(2.88, 12.51) 3 1.71(0.43, 3.81)
Chongqing 5 1.33(0.50, 2.54) 2 2.22(0.19, 6.36) 3 0.97(0.18, 2.37)
Northeast Liaoning 6 5.84(3.87, 8.18) 5 5.00(3.29, 7.06) 1 11.82(8.29,15.89)
Heilongjiang 4 4.06(2.86, 5.47) 4 4.06(2.86, 5.47)
Jilin 5 5.38(2.26, 9.69) 3 7.19(1.08, 18.03) 2 3.59(0.17, 16.81)
Pooled 268 8.68(8.01,9.39) 189 12.87(11.25,14.56) 69 1.71(1.43, 1.99)
a. IM: Inner Mongolia.
b. When calculating the pooled prevalence rate either before or after 1998 respectively, the studies that spanned 1998 were excluded. In that case, number of
total literatures is bigger than the sum of literature number before 1998 and after 1998.
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1998.
Gender
A total of 79 studies have investigated the association
between the prevalence rate of HCV infection and gen-
der among blood donors. HCV infection rate of male
blood donors was 9.87% (95%CI: 8.26%-11.63%), while
female blood donors had a rate of 9.78% (95%CI: 7.88%-
11.89%). There was no significant statistical difference
between males and females (Z = 0.62, P = 0.54).
Age
There were 30 studies indicating the association
between the prevalence rate of HCV infection and age
among blood donors. In most studies blood donors
were divided into two groups by the age of 30 years old.
HCV infection rate of individuals aged 18-30 was 4.91%
(95% CI: 3.89%-6.05%), while the prevalence rate of indi-
viduals aged 31-60 was 8.99% (95% CI: 6.86%-11.37%),
and there was significant statistical difference between
two groups (Z = 66.02, P < 0.01).
Time
As presented in Table 2, 179 studies were divided into 9
groups according to the study period, and Figure 4 was
drawn on the prevalence of HCV in each group. During
1994-1995, the prevalence rate reached the highest,
which was 15.78% (95% CI: 12.21%-19.75%). Since 1995,
the rates showed a decreasing trend among blood
donors, even as low as 0.36% (95% CI: 0.09%-0.81%)
during 2006-2010.
Blood type
As displayed in Table 3, among blood type A, B, AB,
and O donors, the HCV infection rates were 8.18% (95%
CI: 4.55%-12.77%), 7.58% (95%CI: 4.26%-11.73%), 8.15%
(95%CI: 4.64%-12.54%), and 7.85% (95%CI: 4.64%-
11.82%), respectively. There was no significant statistical
difference among four blood types (c
2 = 4.97, P = 0.17).
Prevalence rate (%) 
Figure 2 The regional distribution of pooled prevalence of HCV infection among blood donors in China before 1998.
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As seen in Table 4, HCV infection rate of voluntary
blood donors and paid blood donors were 0.97% (95%
CI: 0.79%-1.16%) and 15.53% (95% CI: 13.28%-17.91%)
respectively. There was significant statistical difference
(Z = 325.65, P < 0.01). The prevalence of HCV infection
differed significantly (Z = 142.22, P < 0.01) among
plasma donors and whole blood donors, which was
7.90% (95%CI: 6.44%-9.51%) and 33.95% (95%CI:
29.80%-38.17%), respectively.
Prevalence rate (%) 
Figure 3 The regional distribution of pooled prevalence of HCV infection among blood donors in China after 1998.
Table 2 Prevalence of HCV infection among blood donors
at different study period
Study
period
No. of
studies
Prevalence of
HCV
% (95%CI)
Heterogeneity Model
I
2 P
value
1990-1991 8 13.42(5.79, 23.62) 98.90% 0.00 REM
1992-1993 48 13.66(9.93,17.87) 99.70% 0.00 REM
1994-1995 57 15.78(12.21,19.75) 99.80% 0.00 REM
1996-1997 23 7.34(5.40,9.54) 99.30% 0.00 REM
1998-1999 13 3.97(2.67,5.54) 98.50% 0.00 REM
2000-2001 7 4.45(0.48,12.08) 99.90% 0.00 REM
2002-2003 14 2.34(1.17,3.87) 99.50% 0.00 REM
2004-2005 4 1.65(0.56,3.29) 97.40% 0.00 REM
2006-2010 5 0.36(0.09,0.81) 99.30% 0.00 REM
REM: random effect model.
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Figure 4 Prevalence of HCV infection among blood donors at
different study period.
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As a blood-borne pathogen, HCV virus was frequently
detected among paid blood donors in China in the early
1990s [9]. To improve the safety of blood supply and
reduce the risk of transfusion-transmitted diseases, the
Chinese government has outlawed the use of paid blood
donors since 1998. As a result, Chinese blood banks
now rely on various other methods to recruit blood
donors, mostly on employer-organized donors and true
voluntary donors [274]. This transition in the blood
donor recruitment methods has been associated with a
gradual decrease in the prevalence of anti-HCV among
donors. In addition, an HCV RNA screening strategy
was implemented in 2010 in all Chinese blood banks,
which has also contributed to the decline of HCV preva-
lence rate. This review shows that the pooled prevalence
of HCV infection among blood donors was 8.68% (95%
CI: 8.01% to 9.39%) from 1990 to 2010, significantly
higher than the estimated 3.2% in the general population
of China [1]. It is noteworthy that before 1998 the
pooled prevalence of HCV infection was 12.87% among
blood donors, but dramatically decreased to 1.71% after
1998. In economically developed regions, the decreasing
trend was more prominent due to effective control
measures.
Our results showed significant geographic difference
of the prevalence of anti-HCV. Compared with other
regions, North and Central China had relatively higher
anti-HCV positive rates among blood donors, account-
ing for 13.45% and 14.74%. Meanwhile, the lowest epi-
demic rate was found in South China with a percentage
of 2.88%. Notably, during the period through 1990 and
1998, the prevalence rates were commonly at high level
among different regions of China. Especially in Henan
and Hebei, the rates even reached 35.04% and 29.26%
respectively. After 1998, the general epidemic rates have
rapidly decreased, benefited from the government’s pro-
hibition of using paid blood donors. However, the
reduction of HCV prevalence was not that obvious in
North and Central China. Possible reasons for this lack
of reduction may include larger population migration,
poor economic conditions, higher HCV infection rates
in the general populations, or limited sampling.
According to the national epidemiological survey of
viral hepatitis from 1992 to 1995, HCV infection rate
among the general population increased gradually with
age, but the prevalence rate had no significant difference
between male and female [275], which is consistent with
our findings that significant difference was found
between two age groups but not between gender. The
findings indicated that both male and female had the
same susceptibility to HCV infection, while the older
had increased chance of being HCV-infected. Since the
paid donors were usually driven by economic benefits,
the association of age with HCV infection may also be
explained by increased exposure chances with a greater
number of instances of blood donation times or longer
duration of blood donation. It is early for a conclusive
explanation until systematic investigations are per-
formed and causal relation underneath is revealed
[35,61,65,153,179].
By and large, the prevalence rate of HCV infection
showed a rising trend among blood donors from 1990
to 1995, but significantly decreased from 1996 to 2010
(Figure 3). Our results revealed an outbreak of HCV
infection in blood donors around 1995. As recalled, lots
of plasma collection stations were established in differ-
ent regions before 1995. However, the majority of them
were illegal and severe cross-contamination on plasma-
pheresis frequently occurred due to those commonly
existed nonstandard operations, such as neglecting steri-
lization, lacking accurate detection method of anti-HCV,
improperly usage of non-disposable needles. In some
places, the prevalence rate of HCV was reported as high
as 80% [275]. Given the urgency of the situation, in
Table 3 Prevalence of HCV infection among blood donors
of different blood type
Blood
type
No. of
studies
Prevalence of
HCV
% (95%CI)
Heterogeneity Model
I
2 P
value
A 14 8.18(4.55,12.77) 98.80% 0.00 REM
B 14 7.58(4.26,11.73) 98.80% 0.00 REM
AB 14 8.15(4.64,12.54) 94.90% 0.00 REM
O 14 7.85(4.64,11.82) 98.80% 0.00 REM
REM: random effect model.
Table 4 Prevalence of HCV infection among blood donors of different donation types
Donation type No. of studies Prevalence of HCV% (95%CI) Heterogeneity Model
I
2 P value
voluntary donation 73 0.97(0.79,1.16) 99.60% 0.00 REM
paid donation 89 15.53(13.28,17.91) 99.70% 0.00 REM
whole blood donors 53 7.90(6.44,9.51) 98.50% 0.00 REM
plasma donors 64 33.95(29.80,38.17) 99.40% 0.00 REM
REM: random effect model.
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on blood stations. Besides, the detection technology of
anti-HCV got greatly improved with better sensitivity
and specificity in the following years [276]. With the
implementation of Blood Donation Law of China in
1998, real voluntary blood donors replaced paid donors
and became a steady and major source of the blood sup-
ply. All these measures lead to the great achievements in
control and prevention of HCV infection. Nowadays
reports of HCV infection among the true voluntary
blood donors could rarely been seen in China.
Our study showed that among blood type A, B, AB,
and O donors, the prevalence of HCV infection were
8.18%, 7.58%, 8.15%, and 7.85%, respectively. No signifi-
cant difference was found between blood types and the
epidemic rate of HCV, indicating that blood type is not
associated with susceptibility to HCV infection. This
finding was consistent with the studies of Lu KQ [52],
Zhou ZD [119], and Pu SF [269]. While it was a differ-
ent story in the study of Ye C [239], in which type O
blood donors were reported to have a higher infection
rate, and type AB showed relatively lower rate. Uneven
distribution with blood type was also seen in Rui ZL’s
study, in which type A blood donors were reported to
have a higher rate [131]. However, the mechanism
between blood type and HCV infection remained unde-
fined, which may be related to red cell immune adher-
ence function among persons with different blood types,
but it need further study [131].
Numerous research has showed that paid blood
d o n o r sa r em o r el i k e l yt ob ei n f e c t e dw i t hH C Vt h a n
both employer-organized donors or true voluntary
donors. Our results confirmed that HCV infection rate
in paid blood donors was significantly higher than in
voluntary blood donors (15.53% vs 0.97%). Those paid
donors who were attracted by high compensation and
chose to donate blood in illegal blood stations, also
risked a greater risk of cross-contamination. The preva-
lence rate among plasma donors was significantly higher
than among whole blood donors (33.95% vs 7.90%), pos-
sibly due to cross-contamination of blood collection
equipment by HCV positive plasma donors [77]. The
elimination of paid plasma and whole blood donation
could contribute to a reduction in HCV infection
among blood donors.
Several limitations in our study need to be addressed.
First of all, the studies were observational and blood
donors were not randomly chosen. Therefore selection
bias and confounding seems inevitable. Secondly, many
of our data were extracted from studies written in
Chinese, which makes it difficult for non-Chinese
reviewers, editors, and readers to trace back to the origi-
nal materials. Thirdly, our ability to assess study quality
was limited by the fact that many studies failed to offer
detailed information of selected subjects or valid data on
important factors. Besides, as with all meta-analyses, this
study has potential limitation of publication bias. Nega-
tive trials are sometimes less likely to be published.
However, we have confidence on our results since the
included literatures were mostly from multi-resources
and had large sample size, which should reduce publica-
tion bias to some extent.
Conclusions
This meta-analysis provides a comprehensive and reli-
able data on the prevalence and trend of HCV infection
among blood donors. The pooled epidemic rate of HCV
infection has rapidly decreased after 1998, though some
provinces still showed relatively high prevalence.
Achievements and lessons in previous work indicated
that long-term, comprehensive and effective interven-
tions and preventions are urgently needed. In particular,
implementing and enforcing the “Blood Donation Law”
and promoting HCV screening, diagnosis, and treatment
among blood donors are very important measures to
control the transmission of HCV infection. In addition,
the key to reduce the incidence of HCV infection
among blood donors is to encourage true voluntary
blood donation, pay more attention to exclude those
high-risk persons from the volunteers, and eliminate
cross-infection completely when collecting single
plasma.
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